Investment analysts at Morgan Stanley began coverage on shares of Afya (NASDAQ:AFYA) in a note issued to investors on Tuesday, MarketBeat.com reports. The brokerage set an “overweight” rating and a $29.20 price target on the stock. Morgan Stanley’s target price would suggest a potential upside of 20.46% from the stock’s current price.
A number of other analysts also recently weighed in on the stock. JPMorgan Chase & Co. initiated coverage on shares of Afya in a report on Friday, August 9th. They issued an “overweight” rating and a $34.00 target price on the stock. Bank of America initiated coverage on shares of Afya in a report on Tuesday. They issued a “buy” rating and a $29.00 target price on the stock.
Afya stock opened at $24.24 on Tuesday. Afya has a twelve month low of $22.00 and a twelve month high of $29.37.
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company provides educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
See Also: What is the LIBOR?
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.